[1] POLIVKA J JR, POLIVKA J, HOLUBEC L, et al. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme. Anticancer Res. 2017;37(1):21-33.
[2] RICE T, LACHANCE DH, MOLINARO AM, et al. Understanding inherited genetic risk of adult glioma - a review. Neurooncol Pract. 2016;3(1):10-16.
[3] GIAMMALVA GR, IACOPINO DG, AZZARELLO G, et al. End-of-Life Care in High-Grade Glioma Patients. The Palliative and Supportive Perspective. Brain Sci. 2018;8(7): E125.
[4] BASU B, GHOSH MK. Extracellular Vesicles in Glioma: From Diagnosis to Therapy. Bioessays. 2019;41(7):e1800245.
[5] CARUSO BAVISOTTO C, GRAZIANO F, RAPPA F, et al. Exosomal Chaperones and miRNAs in Gliomagenesis: State-of-Art and Theranostics Perspectives. Int J Mol Sci. 2018;19(9): E2626.
[6] KALLURI R. The biology and function of exosomes in cancer. J Clin Invest. 2016;126(4):1208-1215.
[7] AGETA H, TSUCHIDA K. Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs. Cell Mol Life Sci. 2019;76(24):4829-4848.
[8] MINETTI G, ACHILLI C, PEROTTI C, et al. Continuous Change in Membrane and Membrane-Skeleton Organization During Development From Proerythroblast to Senescent Red Blood Cell. Front Physiol. 2018;9:286.
[9] SUN B, PENG J, WANG S, et al. Applications of stem cell-derived exosomes in tissue engineering and neurological diseases. Rev Neurosci. 2018;29(5):531-546.
[10] JAYASEELAN VP. Emerging role of exosomes as promising diagnostic tool for cancer. Cancer Gene Ther. 2019 Sep 3. doi: 10.1038/s41417-019-0136-4. [Epub ahead of print]
[11] SHEEHAN C, D'SOUZA-SCHOREY C. Tumor-derived extracellular vesicles: molecular parcels that enable regulation of the immune response in cancer. J Cell Sci. 2019;132(20): jcs235085.
[12] INDIRA CHANDRAN V, WELINDER C, Gonçalves de Oliveira K, et al. Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics. J Neurooncol. 2019;144(3):477-488.
[13] ZHANG K, ZHANG X, CAI Z, et al. A novel class of microRNA- recognition elements that function only within open reading frames. Nat Struct Mol Biol. 2018;25(11):1019-1027.
[14] LEE SWL, PAOLETTI C, CAMPISI M, et al. MicroRNA delivery through nanoparticles. J Control Release. 2019;313:80-95.
[15] GOLDIE BJ, DUN MD, LIN M, et al. Activity-associated miRNA are packaged in Map1b-enriched exosomes released from depolarized neurons. Nucleic Acids Res. 2014;42(14):9195-9208.
[16] GUDURIC-FUCHS J, O'CONNOR A, CAMP B, et al. Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genomics. 2012;13:357.
[17] ZHU Q, WANG Z, HU Y, et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep. 2012;27(5):1660-1668.
[18] ZHANG J, LI S, LI L, et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015;13(1):17-24.
[19] KOSAKA N, IGUCHI H, HAGIWARA K, et al. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem. 2013;288(15):10849-10859.
[20] VILLARROYA-BELTRI C, GUTIÉRREZ-VÁZQUEZ C, SÁNCHEZ-CABO F, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980.
[21] BALAGUER N, MORENO I, HERRERO M, et al. Heterogeneous nuclear ribonucleoprotein C1 may control miR-30d levels in endometrial exosomes affecting early embryo implantation. Mol Hum Reprod. 2018;24(8):411-425.
[22] SANTANGELO L, GIURATO G, CICCHINI C, et al. The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. Cell Rep. 2016;17(3): 799-808.
[23] KOPPERS-LALIC D, HACKENBERG M, BIJNSDORP IV, et al. Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes. Cell Rep. 2014;8(6):1649-1658.
[24] SHURTLEFF MJ, TEMOCHE-DIAZ MM, KARFILIS KV, et al. Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cell-free reaction. Elife. 2016;5: e19276.
[25] MCKENZIE AJ, HOSHINO D, HONG NH, et al. KRAS-MEK Signaling Controls Ago2 Sorting into Exosomes. Cell Rep. 2016;15(5):978-987.
[26] LU P, LI H, LI N, et al. MEX3C interacts with adaptor-related protein complex 2 and involves in miR-451a exosomal sorting. PLoS One. 2017;12(10):e0185992.
[27] ZHANG Z, LI X, SUN W, et al. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Cancer Lett. 2017;397:33-42.
[28] RICHES A, CAMPBELL E, BORGER E, et al. Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway. Eur J Cancer. 2014;50(5):1025-1034.
[29] TŰZESI Á, KLING T, WENGER A, et al. Pediatric brain tumor cells release exosomes with a miRNA repertoire that differs from exosomes secreted by normal cells. Oncotarget. 2017;8(52):90164-90175.
[30] FIGUEROA J, PHILLIPS LM, SHAHAR T, et al. Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. Cancer Res. 2017;77(21):5808-5819.
[31] SAKR M, TAKINO T, SABIT H, et al. miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase.Gene.2016;587(2): 155-162.
[32] LEI W, YAN C, YA J, et al. MiR-199a-3p affects the multi-chemoresistance of osteosarcoma through targeting AK4. BMC Cancer. 2018;18(1):631.
[33] CAI Q, ZHU A, GONG L. Exosomes of glioma cells deliver miR-148a to promote proliferation and metastasis of glioblastoma via targeting CADM1. Bull Cancer. 2018;105(7-8):643-651.
[34] THURINGER D, CHANTELOUP G, BOUCHER J, et al. Modulation of the inwardly rectifying potassium channel Kir4.1 by the pro-invasive miR-5096 in glioblastoma cells. Oncotarget. 2017;8(23):37681-37693.
[35] SHARIF S, GHAHREMANI MH, SOLEIMANI M. Delivery of Exogenous miR-124 to Glioblastoma Multiform Cells by Wharton's Jelly Mesenchymal Stem Cells Decreases Cell Proliferation and Migration, and Confers Chemosensitivity. Stem Cell Rev Rep. 2018; 14(2):236-246.
[36] YANG JK, YANG JP, TONG J, et al. Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma. J Neurooncol. 2017;131(2):255-265.
[37] YIN J, ZENG A, ZHANG Z, et al. Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma. EBioMedicine. 2019;42:238-251.
[38] YUE X, LAN F, XIA T. Hypoxic Glioma Cell-Secreted Exosomal miR-301a Activates Wnt/β-catenin Signaling and Promotes Radiation Resistance by Targeting TCEAL7. Mol Ther. 2019;27(11):1939-1949.
[39] GUO X, QIU W, WANG J, et al. Glioma exosomes mediate the expansion and function of myeloid-derived suppressor cells through microRNA-29a/Hbp1 and microRNA-92a/Prkar1a pathways. Int J Cancer. 2019;144(12):3111-3126.
[40] GUO X, QIU W, LIU Q, et al. Immunosuppressive effects of hypoxia- induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways. Oncogene. 2018; 37(31):4239-4259.
[41] QIAN M, WANG S, GUO X, et al. Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways. Oncogene. 2019 Sep 4. doi: 10.1038/s41388-019-0996-y. [Epub ahead of print]
[42] SHBOUL ZA, ALAM M, VIDYARATNE L, et al. Feature-Guided Deep Radiomics for Glioblastoma Patient Survival Prediction. Front Neurosci. 2019;13:966.
[43] SHI R, WANG PY, LI XY, et al. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients. Oncotarget. 2015;6(29):26971-26981.
[44] SANTANGELO A, IMBRUCÈ P, GARDENGHI B, et al. A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker. J Neurooncol. 2018;136(1): 51-62.
[45] LANG FM, HOSSAIN A, GUMIN J, et al. Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas. Neuro Oncol. 2018;20(3):380-390.
[46] KIM R, LEE S, LEE J, et al. Exosomes derived from microRNA-584 transfected mesenchymal stem cells: novel alternative therapeutic vehicles for cancer therapy. BMB Rep. 2018;51(8):406-411.
[47] MONFARED H, JAHANGARD Y, NIKKHAH M, et al. Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma. Front Oncol. 2019;9:782.
[48] FAREH M, ALMAIRAC F, TURCHI L, et al. Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth. Cell Death Dis. 2017;8(3):e2713.
[49] ZHOU J, GUO H, YANG Y, et al. A meta-analysis on the prognosis of exosomal miRNAs in all solid tumor patients. Medicine (Baltimore). 2019;98(16):e15335.
[50] LAN F, QING Q, PAN Q, et al. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma. Cell Oncol (Dordr). 2018;41(1):25-33.
[51] SHI H, FANG X, LI Y, et al. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients. Med Sci Monit. 2019;25:7430-7438.
[52] WANG ZF, LIAO F, WU H, et al. Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma. J Exp Clin Cancer Res. 2019;38(1):201.
|